RxDoctor Payments Data

Jessica Cashwell

Adult Health · Thomasville, GANPI 1295377000

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 294 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,837in general payments, 2019–2025

Across 294 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$658
  • Johnson & Johnson$538
  • Amgen$486
  • Pfizer$446
  • E.r. Squibb & Sons, L.L.C.$428
  • Boehringer Ingelheim$357
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,837100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,837 in reported general payments places this provider in the 90th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin66$42,959
EntrestoSacubitril/Valsartan53$34,451
FarxigaDapagliflozin Propanediol37$24,906
EliquisApixaban41$24,518
XareltoRivaroxaban22$12,418
Ranolazine ErRanolazine20$1,113
Metoprolol Succinate97$626
Potassium Chloride46$548
Rosuvastatin Calcium36$369
Atorvastatin Calcium66$368
Diltiazem 24hr Er (La)Diltiazem Hcl13$346
Carvedilol46$214
Torsemide13$157
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$144
Losartan Potassium30$143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$357$42,95966 claims
NovartisEntresto$355$34,45153 claims
AstraZenecaFarxiga$240$24,90637 claims
PfizerEliquis$446$24,51841 claims
Johnson & JohnsonXarelto$538$12,41822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 577 adult health providers in Georgia.

Other adult health in Thomasville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →